-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
How can we effectively identify and report clinical research misconduct?
Glenda Guest
Editorial: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation